Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma. - Wikidata - wikimedia - TriplyDB

Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma.

Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma.

http://www.wikidata.org/entity/Q35915614

about

Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer Improving cancer immunotherapy by targeting the STATe of MDSCs Local Immune Responsiveness of Mice Bearing Premalignant Oral Lesions to PD-1 Antibody Treatment.Decreased expression of CYP27B1 correlates with the increased aggressiveness of ovarian carcinomas.Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma Immunotherapy for head and neck cancer: advances and deficiencies.Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck.Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer.Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis.A prospective study of serum 25-hydroxyvitamin d levels and mortality among African Americans and non-African Americans.Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer.Immune regulatory activity of vitamin d3 in head and neck cancer Premalignant Oral Lesion Cells Elicit Increased Cytokine Production and Activation of T-cells.Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets.Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer.Vitamin D Control of Hematopoietic Cell Differentiation and Leukemia.Redirecting the focus of cancer immunotherapy to premalignant conditions.Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancer.Posttraumatic Stress Disorder: An Immunological Disorder?Targeting Myeloid-Derived Suppressor Cells in Cancer.Influence of vitamin D on cancer risk and treatment: Why the variability?

P2860

Q26863418-F2D84217-26BF-4D24-B2DD-BA6836003A68 Q28066797-A59A8F65-82BD-4534-8D1F-F0F13D1AE0BA Q33832752-B46D1C40-7628-4498-9D72-39D6C4A187EF Q35012503-21EDC599-5FA5-40D5-B488-8F638E577243 Q35067627-9F939BE4-E4A9-4E27-9B38-D19167A4167D Q35072040-FC7AF894-AD55-4ED2-9F57-1FD643529E9D Q35922983-CFCF0221-7258-4D7B-A935-09AD8E6AC78B Q36029715-7C09D761-0B8F-4D5F-A9F8-747377B2D732 Q36102797-6E683732-189B-4C58-80CE-49211E46F62D Q36522942-E0B0F1B4-76F9-4698-82F4-CAB38BA55F4F Q37017190-E2C271FE-C910-46A0-BA33-DD143115689E Q37226517-C8FC3076-3E91-4DB3-8B01-AD9805E342CD Q37274307-43603984-3466-4124-A7F3-E1409E380C38 Q37664203-C7373923-770F-44C0-9147-1A67D7998C1D Q38161874-A0F49321-5790-431A-A8A5-531D4E0FD903 Q38269370-5EC591C0-8DF6-4D23-81B8-1ED6F352C287 Q38610901-398FB19C-EADE-4380-928D-028AAB3C9817 Q39037456-C78B3CE3-E5CA-450F-BAC0-2033BBDF1C2C Q39107022-35472269-493A-48D3-8D2D-BB66F656651D Q41999286-D7FDBD8D-D2E0-4857-813F-69FC0B53F448 Q47130878-2E40E1D0-DF53-4E8C-806B-5278F1479AE5 Q47765346-DC846DC6-60CA-4ACA-9ED6-F19E7712B97F Q58133485-D99D2A87-6CB5-4AD8-AFBB-EF0B1EA42CB2

P2860

Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma.

http://www.wikidata.org/entity/Q35915614

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Use of alpha,25-dihydroxyvitam ...... neck squamous cell carcinoma.

@ast

Use of alpha,25-dihydroxyvitam ...... neck squamous cell carcinoma.

@en

type

label

Use of alpha,25-dihydroxyvitam ...... neck squamous cell carcinoma.

@ast

Use of alpha,25-dihydroxyvitam ...... neck squamous cell carcinoma.

@en

prefLabel

Use of alpha,25-dihydroxyvitam ...... neck squamous cell carcinoma.

@ast

Use of alpha,25-dihydroxyvitam ...... neck squamous cell carcinoma.

@en

P1433

Q35915614-14A742A7-2C4E-4F72-AA8C-91789190334C

P1476

Q35915614-5471CF91-047D-4728-BB28-F51B6D27DD3B

P2093

Q35915614-68D0EF08-50E8-4AB1-9450-CF7F09B6DB92

Q35915614-A2B17C27-F963-4F09-B442-C1FD5D68FEDF

Q35915614-C234FD18-E35D-43C7-B10C-B268217C7178

Q35915614-EBF37780-448B-4661-99F1-61F9A9DB36E6

Q35915614-F99DC2FB-538A-4B7E-B420-12DE39F2961D

P2860

Q35915614-04EBE3B7-9192-4F6F-B61F-B5C534757A67

Q35915614-0C955A93-8BE6-4D88-BD88-D2EAF31AA4ED

Q35915614-0D63016C-8813-483F-A990-3284A8460DE3

Q35915614-1EE4422D-3E61-4927-99A0-EE6249E929A9

Q35915614-2EADF8BE-A51C-4AB0-9A21-A688A60D61E0

Q35915614-3562271F-8B9A-4F5F-AB75-41F3AD8E728A

Q35915614-3A7B2BFF-5C2B-4179-900C-9763373D4FA5

Q35915614-3A7E5080-460F-47D1-B204-D07F9F6604F7

Q35915614-5CDEC64A-ED1C-480D-999D-1017B650F561

Q35915614-7E56F005-D3C0-4B80-AAE0-7D9DEB876BBE

P304

Q35915614-62476DB3-40A8-4480-B875-16F50C3D49FE

P31

Q35915614-28268C0C-4B2F-4518-8698-1C9D45B47F9B

P356

Q35915614-8D07D12E-AEEB-43CE-9F9C-AE87E4A066D9

P433

Q35915614-DFD6602A-0B14-493A-A5A1-1C43E476A5FC

P478

Q35915614-C171AACB-E2AF-4A0F-A18A-1819D5CE502A

P577

Q35915614-994813FE-FC19-4191-8DEF-5AD81A839368

P5875

Q35915614-DA21DC4B-5BBF-4F1D-A821-AEFEE1DBE80A

P698

Q35915614-63D3DF88-345E-4C2D-9657-CE2C6E2EDC3A

P932

Q35915614-FF0AC8AD-C178-423C-BCC2-A11F61D1C708

P356

J.HUMIMM.2010.04.008

P1433

Human Immunology

P1476

Use of alpha,25-dihydroxyvitam ...... neck squamous cell carcinoma.

@en

P2093

Anna-Maria Clark

http://www.w3.org/2001/XMLSchema#string

Jarrett E Walsh

http://www.w3.org/2001/XMLSchema#string

M Boyd Gillespie

http://www.w3.org/2001/XMLSchema#string

M Rita I Young

http://www.w3.org/2001/XMLSchema#string

Terry A Day

http://www.w3.org/2001/XMLSchema#string

P2860

Unique regulation of CCL18 production by maturing dendritic cells

Indomethacin sensitive suppressor-cell activity in head and neck cancer patients. The role of the adherent mononuclear cell.

Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease.

Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers.

1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells.

Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia.

Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells.

Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.

Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance.

Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study.

P304

659-665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HUMIMM.2010.04.008

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44569746

http://www.w3.org/2001/XMLSchema#string

P698

20438786

http://www.w3.org/2001/XMLSchema#string

P932

3337687

http://www.w3.org/2001/XMLSchema#string